We finally examined whether NF-κB/PGC-1α signaling gets involved in the correction of cardiac energy biosynthesis dysfunction by ASIV, subsequently contributing to the protection against cardiac hypertrophy. The gene discussed is NFKB1; the disease is cardiac hypertrophy.